摘要
《生物医学研发一体化战略规划》由美国武装部队生物医学研究评估与管理中心编制,是美国国防部发布的针对生物医学领域的一体化战略规划,对推动美军生物医学发展及确保部队在未来联合作战环境中顺利履行国防部任务职责具有深远影响。该文对美军《生物医学研发一体化战略规划》的战略目标、主要内容及重点等进行全面解读和系统分析,为推动我军生物医学科技发展,全面提升生物医学保障效能提供了有价值的参考。
The Integrated Biomedical Research and Development Strategy,compiled by Armed Services Biomedical Research,Evaluation and Management(ASBREM)Community of Interest(Co I),is a strategy for biomedicine released by the U.S.Department of Defense,which has a profound impact on promoting the development of biomedicine in the U.S.Armed Forces and ensuring that the troops perform their duties in the future joint combat environment.This article makes a comprehensive interpretation and systematic analysis of its strategic objectives,main contents and key points so as to provide valuable references for us to promote the development of biomedicine and the effectiveness of health service in China.
作者
张音
王磊
楼铁柱
ZHANG Yin;WANG Lei*;LOU Tie-zhu(Institute of Health Service and Transfusion Medicine,Academy of Military Medical Sciences,Academy of MilitarySciences,Beijing 100850,China)
出处
《军事医学》
CAS
CSCD
北大核心
2018年第11期801-803,共3页
Military Medical Sciences
关键词
美军
生物医学研发一体化战略规划
解读
U.S.Armed Forces
Integrated Biomedical Research and Development Strategy
interpretation